Sialorrhea is a common and often debilitating, socially isolating and embarrassing symptom for patients with Parkinson disease (PD). The treatment of sialorrhea involves the management of saliva ...

Incobotulinumtoxin A is under clinical development by Merz Therapeutics and currently in Phase I for Unspecified Dermatological Disorders.